Enteropathy and gut dysbiosis as obstacles to achieve immune recovery in undetectable people with HIV: a clinical view of evidence, successes, and projections
- PMID: 36695354
- DOI: 10.1097/QAD.0000000000003450
Enteropathy and gut dysbiosis as obstacles to achieve immune recovery in undetectable people with HIV: a clinical view of evidence, successes, and projections
Abstract
Immune performance following antiretroviral therapy initiation varies among patients. Despite achieving viral undetectability, a subgroup of patients fails to restore CD4+ T-cell counts during follow-up, which exposes them to non-AIDS defining comorbidities and increased mortality. Unfortunately, its mechanisms are incompletely understood, and no specific treatment is available. In this review, we address some of the pathophysiological aspects of the poor immune response from a translational perspective, with emphasis in the interaction between gut microbiome, intestinal epithelial dysfunction, and immune system, and we also discuss some studies attempting to improve immune performance by intervening in this vicious cycle.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- UNAIDS. Global HIV statistics . Fact Sheet 2021; 1–3.
-
- UNAIDS. UNAIDS data 2020 . Program HIV/AIDS 2020; 1:1–436.
-
- Deeks SG, Overbaugh J, Phillips A, Buchbinder S. HIV infection . Nat Rev Dis Prim 2015; 1:1–22.
-
- Kelly C, Gaskell KM, Richardson M, Klein N, Garner P, MacPherson P. Discordant immune response with antiretroviral therapy in HIV-1: a systematic review of clinical outcomes . PLoS One 2016; 11:e0156099.
-
- Van Lelyveld SFL, Gras L, Kesselring A, Zhang S, De Wolf F, Wensing AMJ, et al. Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort . AIDS 2012; 26:465–474.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
